Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG
about
The Surprising Role of Amyloid Fibrils in HIV InfectionLiquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection.Semen amyloids participate in spermatozoa selection and clearanceInteraction of fibronectin with semen amyloids synergistically enhances HIV infection.Morphology-Dependent HIV-Enhancing Effect of Semen-Derived Enhancer of Viral Infection.Inhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles.Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotideEpigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.Zinc reduces epithelial barrier compromise induced by human seminal plasma.Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen.Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis.Green tea in dermatology--myths and facts.A Review of the Antiviral Role of Green Tea Catechins.Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha.Brazilin Inhibits Prostatic Acidic Phosphatase Fibrillogenesis and Decreases its Cytotoxicity.Antiviral Mechanism of Action of Epigallocatechin-3--gallate and Its Fatty Acid Esters
P2860
Q33570363-32E55093-A457-4900-A6AB-F59DFBCDBDCCQ33744114-07C46BE5-25F9-4950-BB04-3BB7CD64DD92Q33842506-16863D5A-C82A-4EF9-B2AC-7D253698C257Q34209036-A63A51BB-3095-498F-B07C-27C88B97CB8EQ35530002-D02DD2D9-8B7E-4B1E-8CC3-D323F8E2D3CCQ35589369-253C63CE-6D97-49DC-8CBE-730B7989DEA4Q36083853-B157FDDA-1EF9-4693-87DC-7D53F46E766CQ36090859-84F1D2D0-B878-4B36-9A7B-1B1BBFD67B3DQ36302628-7BA4F855-622D-4BE9-A5DB-9C10CE2904AFQ36318054-AFC3BC7D-056C-4195-8A6B-BF4AD4E27559Q37026734-28E52649-08A5-4BE0-ACCC-A2E1A774B946Q38103193-508487D2-D421-44F8-8856-EA8649737C0DQ38547575-682211D1-6447-43A1-A29C-5807E47C4455Q38626136-5DAF4CEB-D119-47CC-B524-B90833135142Q38787044-23D8BDA3-F273-42E5-96FC-816302FB8021Q40288210-949D58F5-5931-4302-B780-378A4487F447Q58697352-BEB7DB04-0A1A-4755-8218-76C566A0B327
P2860
Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Assessment of the range of the ...... he range of inhibition by EGCG
@ast
Assessment of the range of the ...... he range of inhibition by EGCG
@en
type
label
Assessment of the range of the ...... he range of inhibition by EGCG
@ast
Assessment of the range of the ...... he range of inhibition by EGCG
@en
prefLabel
Assessment of the range of the ...... he range of inhibition by EGCG
@ast
Assessment of the range of the ...... he range of inhibition by EGCG
@en
P2093
P2860
P356
P1476
Assessment of the range of the ...... he range of inhibition by EGCG
@en
P2093
Adriana Thomssen
Barbara Holstermann
Heinrich Hohenberg
Ilona Hauber
Philip Hartjen
Sebastian Frerk
Verena Matzat
Wolfgang Schulze
P2860
P2888
P356
10.1186/1742-6405-9-2
P577
2012-01-19T00:00:00Z
P5875
P6179
1014963563